Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127475661 | 12747566 | 1 | I | 20160525 | 20160915 | 20160915 | PER | US-JAZZ-2016-US-009759 | JAZZ | 0.00 | M | Y | 0.00000 | 20160915 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127475661 | 12747566 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
127475661 | 12747566 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
127475661 | 12747566 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
127475661 | 12747566 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.5 G, BID | 21196 | 3.5 | G | ORAL SOLUTION | |||||||
127475661 | 12747566 | 5 | SS | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 6 | C | Fluoxetine hcl | FLUOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 7 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 8 | C | NEURONTIN | GABAPENTIN | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 10 | C | Hydrocodone/acetaminophen | ACETAMINOPHENHYDROCODONE | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 11 | C | Metformin hcl | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 12 | C | ASPIRIN. | ASPIRIN | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 13 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 14 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
127475661 | 12747566 | 15 | C | Multivitamin | VITAMINS | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127475661 | 12747566 | 1 | Narcolepsy |
127475661 | 12747566 | 2 | Cataplexy |
127475661 | 12747566 | 5 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127475661 | 12747566 | Feeling abnormal | |
127475661 | 12747566 | Hyperhidrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127475661 | 12747566 | 1 | 200501 | 200502 | 0 | |
127475661 | 12747566 | 2 | 200502 | 2009 | 0 | |
127475661 | 12747566 | 3 | 201404 | 201405 | 0 | |
127475661 | 12747566 | 4 | 201405 | 0 |